Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study
- PMID: 29792873
- DOI: 10.1016/j.jalz.2018.04.004
Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study
Abstract
Introduction: Cognitive change in people at risk of Alzheimer's disease (AD) such as subjective memory complainers is highly variable across individuals.
Methods: We used latent class growth modeling to identify distinct classes of nonlinear trajectories of cognitive change over 2 years follow-up from 265 subjective memory complainers individuals (age 70 years and older) of the INSIGHT-preAD cohort. We determined the effect of cortical amyloid load, hippocampus and basal forebrain volumes, and education on the cognitive trajectory classes.
Results: Latent class growth modeling identified distinct nonlinear cognitive trajectories. Education was associated with higher performing trajectories, whereas global amyloid load and basal forebrain atrophy were associated with lower performing trajectories.
Discussion: Distinct classes of cognitive trajectories were associated with risk and protective factors of AD. These associations support the notion that the identified cognitive trajectories reflect different risk for AD that may be useful for selecting high-risk individuals for intervention trials.
Keywords: Amyloid PET; Cholinergic basal forebrain; Hippocampus; Longitudinal cognitive change; Preclinical Alzheimer's disease.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Relationship between Basal Forebrain Resting-State Functional Connectivity and Brain Amyloid-β Deposition in Cognitively Intact Older Adults with Subjective Memory Complaints.Radiology. 2019 Jan;290(1):167-176. doi: 10.1148/radiol.2018180268. Epub 2018 Oct 23. Radiology. 2019. PMID: 30351255
-
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.Alzheimers Dement. 2018 Sep;14(9):1204-1215. doi: 10.1016/j.jalz.2018.05.014. Epub 2018 Jul 7. Alzheimers Dement. 2018. PMID: 30201102 Review.
-
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2. Epub 2018 Feb 27. Lancet Neurol. 2018. PMID: 29500152
-
Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study.Alzheimers Res Ther. 2019 Jan 31;11(1):15. doi: 10.1186/s13195-019-0466-3. Alzheimers Res Ther. 2019. PMID: 30704537 Free PMC article.
-
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations.Neuropsychol Rev. 2014 Sep;24(3):300-12. doi: 10.1007/s11065-014-9267-4. Epub 2014 Aug 10. Neuropsychol Rev. 2014. PMID: 25108368 Free PMC article. Review.
Cited by
-
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach.J Alzheimers Dis Rep. 2023 Sep 26;7(1):1055-1076. doi: 10.3233/ADR-230027. eCollection 2023. J Alzheimers Dis Rep. 2023. PMID: 37849637 Free PMC article.
-
In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease.Alzheimers Res Ther. 2021 Oct 21;13(1):178. doi: 10.1186/s13195-021-00918-0. Alzheimers Res Ther. 2021. PMID: 34674764 Free PMC article.
-
Differences in Trajectories and Predictive Factors of Cognition over Time in a Sample of Cognitively Healthy Adults, in Zaragoza, Spain.Int J Environ Res Public Health. 2021 Jul 2;18(13):7092. doi: 10.3390/ijerph18137092. Int J Environ Res Public Health. 2021. PMID: 34281039 Free PMC article.
-
Trajectories of cognitive function in community-dwelling older adults: A longitudinal study of population heterogeneity.Alzheimers Dement (Amst). 2021 May 2;13(1):e12180. doi: 10.1002/dad2.12180. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 33969173 Free PMC article.
-
Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil.Eur Psychiatry. 2021 Feb 15;64(1):e16. doi: 10.1192/j.eurpsy.2021.8. Eur Psychiatry. 2021. PMID: 33583479 Free PMC article. Clinical Trial.
References
-
- S Kielb, E Rogalski, S Weintraub, A Rademaker. Objective features of subjective cognitive decline in a United States national database. Alzheimers Dement. 13: 2017; 1337-1344
-
- MM Machulda, VS Pankratz, TJ Christianson, RJ Ivnik, MM Mielke, RO Roberts, et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. Clin Neuropsychol. 27: 2013; 1247-1264
-
- J Hassenstab, D Ruvolo, M Jasielec, C Xiong, E Grant, JC Morris. Absence of practice effects in preclinical Alzheimer's disease. Neuropsychology. 29: 2015; 940-948
-
- JE Baker, YY Lim, RH Pietrzak, J Hassenstab, PJ Snyder, CL Masters, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-beta: A meta-analysis. Alzheimers Dement (Amst). 6: 2017; 108-121
-
- SE Schindler, MS Jasielec, H Weng, JJ Hassenstab, E Grober, LM McCue, et al. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiol Aging. 56: 2017; 25-32
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical